ARCHIVES

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

This article is from The Cancer Letter archive.

Vol. 32 No. 01 | January 13, 2006

Download PDF Visit The Full Archive

Related Articles

As Zeneca Buys Salick, Implications For Oncology Managed Care Uncertain

April 4, 1997

Obituary: Paul Rogers, Former Congressman, Instrumental In National Cancer Act Passage.

October 17, 2008

United Approach With Other Health Advocates Needed To Increase Cancer Dollars, Royboal Says

February 10, 1978

Clearinghouse Finds Five Compounds Pose Risk To Humans

March 2, 1979

Two activists Are Appointed To Complete NCAB

May 31, 1991

UICC Announces Four Grant award Programs

July 14, 1978